详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Song, Yuqin[1] * ; Zhou, Keshu[2] ; Zou, Dehui[3,4] ; Zhou, Jianfeng[5]

; Hu, Jianda[6] ; Yang, Haiyan[7] ; Zhang, Huilai[8,9] ; Ji, Jie[10] ; Xu, Wei[11] ; Jin, Jie[12] ; Lv, Fangfang[13] ; Feng, Ru[14] ; Gao, Sujun[15] ; Zhou, Daobin[16,17] ; Guo, Haiyi[18,19] ; Wang, Aihua[18,19] ; Hilger, James[18,19] ; Huang, Jane[18,19] ; Novotny, William[18,19] ; Osman, Muhtar[18,19] ; Zhu, Jun[20] ;

单位： [1]Peking Univ, Canc Hosp & Inst, Beijing Canc Hosp, Dept Lymphoma, Beijing, Peoples R China [2]Zhengzhou Univ, Henan Canc Hosp, Canc Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China [3]Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China [4]Peking Union Med Coll, Tianjin, Peoples R China [5]Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Hubei, Peoples R China [6]Fujian Med Univ, Union Hosp, Fujian Prov Key Lab Hematol, Fujian Inst Hematol, Fuzhou, Fujian, Peoples R China [7]Zhejiang Canc Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China [8]Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Natl Clin Res Ctr Canc, Dept Lymphoma,Canc Inst & Hosp, Tianjin, Peoples R China [9]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China [10]West China Hosp Sichuan Univ, Dept Hematol, Chengdu, Sichuan, Peoples R China [11]Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China [12]Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Coll Med, Hangzhou, Zhejiang, Peoples R China [13]Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China [14]Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China [15]Jilin Univ, Canc Ctr, Dept Hematol, Hosp 1, Changchun, Jilin, Peoples R China [16]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China [17]Peking Union Med Coll, Beijing, Peoples R China [18]BeiGene Beijing Co Ltd, Beijing, Peoples R China [19]China & BeiGene USA Inc, San Mateo, CA USA [20]Peking Univ, Dept Lymphoma, Canc Hosp & Inst, Beijing Canc Hosp, Beijing, Peoples R China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2016]版：

Q1 HEMATOLOGY

最新[2024]版：

Q1 HEMATOLOGY

第一作者：

第一作者单位： [1]Peking Univ, Canc Hosp & Inst, Beijing Canc Hosp, Dept Lymphoma, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

文献详情